Skip to main content
SpringerLink
Log in

Concentration-Effect Relationships of Valproic Acid

  • Review Article
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

Summary

Valproic acid is an effective broad spectrum anticonvulsant drug. It has a relatively short half-life, and large diurnal fluctuations in serum concentrations occur, thus making it difficult to define clear relationships between individual serum concentrations and either therapeutic or adverse effects. The value of routine ‘one-off’ measurements of valproate in clinical practice are further reduced by the absence of a clearly defined dose-related neurotoxicity syndrome. The often quoted therapeutic range for valproate of 50 to 100 mg/L has therefore to be regarded with some circumspection, although available data does suggest an increased incidence of adverse reactions with serum concentrations above 100 mg/L.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Barnes, S.E. and Bower, B.D.: Sodium valproate in the treatment of intractable childhood epilepsy. Developmental Medicine and Child Neurology 17: 175–181 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Bellman, M.H. and Ross, E.M.: Side effects of valproate British Medical Journal 2: 166: (1977).

    Google Scholar 

  • Bruni, J.; Wilder. B.J.; Willmore, L.J.: Perchalski. K.J. and Villareal, H.J.: Steady-state kinetics of valproic acid in epileptic patients. Clinical Pharmacology and Therapeutics 24: 324–332 (1978).

    PubMed  CAS  Google Scholar 

  • Chadwick, D.W.; Cummings, W.J.K.; Livingstone, I. and Cartlidge, N.E.F.: Acute intoxication with sodium valproate. Annals of Neurology 6: 552–553 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Chapman, A.; Keane. P.E.; Meldrum. B.S.; Simiand, J. and Vernieres, J.C.: Mechanism of anticonvulsanl action of valproate. Progress of Neurobiology 19: 315–359 (1982).

    Article  CAS  Google Scholar 

  • Chard, C.R.: A simple method for the determination of Epilim in serum; in Legg (Ed.) Clinical and Pharmacological Aspects of Sodium Valproate in the Treatment of Epilepsy, pp. 14–22 (MCS Consultants, Tunbridge Wells 1976).

    Google Scholar 

  • Couvanis, A.; Gupta. A.K. and Jeavons. P.M.: Sodium valproate: Monotherapy and polytherapy. Epilepsia 23: 693–720 (1982).

    Article  Google Scholar 

  • Dam, M. and Gram, L.: Weight changes in epileptic patients treated with valproate; in Dam et al. (Eds) Valproate in the Treatment of Seizures, pp. 83–85 (The Danish Epilepsy Society, Hyidore 1981).

    Google Scholar 

  • Davidson, D.L.W.: A review of the side-effects of sodium valproate. Brit. J. Clin. Practice Suppl. 27: 79–89 (1983).

    Google Scholar 

  • Egger, J. and Breit, E.M.: Effects of sodium valproate in 100 children with special reference to wcighl. British Medical Journal 283: 577–581 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Espir, M.L.E.; Benton, P.; Hayes, M.J.; Will. E. and Walker, G.: Sodium valproate (Epilim). Some clinical and pharmacological aspects; in Legg (Ed.) Clinical and Pharmacological Aspects of Sodium Valproate in the Treatment of Epilepsy, pp. 145–151 (MCS Consultants, Tunbridge Wells 1976).

    Google Scholar 

  • Gram, L.: Flachs. H.: Wurtz-Jorgensen, A.: Parnas, J. and Andersen, B.: Sodium valproate serum level and clinical effects in epilepsy. A controlled study. Epilepsia 20: 303–312 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Grant, R.H.E. and Barot, M.: The use of sodium valproate in severely handicapped patients with epilepsy, in Legg (Ed.) Clinical and Pharmacological Aspects of Sodium Valproate in the Treatment of Epilepsy, pp. 87–91 (MCS Consultants, Tunbridge Wells 1976).

    Google Scholar 

  • Gugler, R. and Von Unruh, G.E.: Clinical Pharmacokinetics of valproic acid. Clinical Pharmacokinetics 5: 67–83 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Gugler, R. and Muller, G.: Plasma protein binding of valproic acid in healthy subjects and in patients with renal disease. British Journal of Clinical Pharmacology 5: 441–446 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Gugler, R.; Schell, A.; Eichelbaum, M.; Froscher, W. and Schulz, H.H.: Disposition of valproic acid in man. European Journal of Clinical Pharmacology 12: 125–132 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Haigh, D. and Forsythe, W.I.: The treatment of childhood epilepsy with sodium valproate: Developmental Medicine and Child Neurology 17: 743–748 (1975).

    PubMed  CAS  Google Scholar 

  • Henriksen, O. and Johannessen, S.J.: Clinical and pharmacokinetic observations on sodium valproate A 5-year follow-up study in 100 children with epilepsy. Acta Neurologica Scandinavica 65: 504–523 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Herranz. J.L.; Artega, R. and Armijo, J.A.: Side effects of sodium valproate in monolherapy controlled by plasma levels: A study in 88 pacdialric patients. Epilepsia 23: 203–14 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Hyman, N.M.: Dennis, P.D. and Sinclair, K.G.A.: Tremor due to sodium valproate. Neurology 29: 1170–1180 (1979).

    Article  Google Scholar 

  • Jeavons, P.M.; Clark, J.E. and Maheshwari, M.C.: Treatment of generalised epilepsies of childhood and adolescence with sodium valproate. Developmental Medicine and Child Neurology 19: 9–25 (1975).

    Article  Google Scholar 

  • Jeavons, P.M.: Valproic acid: Toxicily; in Woodbury et al. (Eds) Anticpileptic Drugs. pp. 601–610 (Raven Press, New York 1982).

    Google Scholar 

  • Johannessen, S.I.: Preliminary observations on valproic acid kinetics in patients with epilepsy. Arzneimittel-Forschung 27: 1083–1085 (1977).

    PubMed  CAS  Google Scholar 

  • Kapetanovic, I.M. and Kupferberg, H.J.: Inhibition of microsomal phenobarbitone metabolism by valproic acid. Biochemical Pharmacology 30: 1361–1363 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Karas, B.J.; Wilder, B.J.; Hammond, E.J. and Bauman, A.W.: Valproate tremors. Neurology 32: 428–432 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Klotz, U. and Antonin, K.H.: Pharmacokinetics and bioavailability of sodium valproate. Clinical Pharmacology and Therapeutics 21: 736–743 (1977).

    PubMed  CAS  Google Scholar 

  • Klotz, U.; Rapp, T. and Muller, W.A.: Disposition of valproic acid in patients with liver disease. European Journal of Clinical Pharmacology 13: 55–60 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Laljee, H.C.K. and Parsonage, M.J.: Unwanted effects of sodium valproate (Epilim) in the treatment of adult patients with epilepsy, in Parsonage and Caldwell (Eds) The Place of Sodium Valproate in the Treatment of Epilepsy, pp. 141–158 (Royal Society of Medicine, London 1980).

    Google Scholar 

  • Loiseau, P.; Brachet, A. and Henry, P.: Concentration of dipropylacetate in plasma. Epilepsia 16: 609–615 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Loiseau, P.; Cenraud, B.; Levy, R.H.; Akbaraly, R.; Brachet-Liermain, A.; Guyot, M. and Morselli, P.L.: Diurnal variations in steady-state plasma concentrations of valproic acid in epileptic patients. Clinical Pharmacokinetics 7: 544–552 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Loscher, W.: Serum protein binding and pharmacokinetics of valproate in man, dog, rat and mouse. Journal of Pharmacology and Experimental Therapeutics 204: 225–261 (1978).

    Google Scholar 

  • Mattson, R.H.; Cramer, J.A.; Williamson, P.D. and Novelly, R.A.: Valproic acid in epilepsy: Clinical and pharmacological effects. Annals of Neurology 3: 20–25 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Meijer, J.W.A. and Hessing-Brand, L.: Determination of lower fatty acid, particularly in the antiepileptic dipropylacetic acid in biological material by means of microdiffusion and gas chromatography. Clinica Chimica Acta 43: 215–222 (1973).

    Article  CAS  Google Scholar 

  • Patel, I.H. and Levy, R.H.: Valproic acid binding to human serum albumin and determination of free fraction in the presence of anticonvulsants and free fatty acids. Epilepsia 20: 85–90 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Perucca, E.; Gatti, G.; Frigo, G.M.; Crema, A.; Calzetti, S. and Visintini, D.: Disposition of sodium valproate in epileptic patients. British Journal of Clinical Pharmacology 5: 495–499 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Pinder, R.M.; Brogden, R.N.; Speight, T.M. and Avery, G.S.: Sodium valproate: A review of its pharmacological properties and therapeutic effects in epilepsy. Drugs 13: 81–123 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Reynolds, E.H.: Serum levels of anticonvulsant drugs: Interpretation and clinical value. Pharmacology and Therapeutics 8: 217–35 (1979).

    Article  Google Scholar 

  • Richens, A.; Scoular, I.T.; Ahmed, S. and Jordan, B.J.: Pharmacokinetics and efficacy of Epilim in patients receiving long term therapy with other antiepileptic drugs; in Legg (Ed.) Clinical and Pharmacological Aspects of Sodium Valproate (Epilim) in the Treatment of Epilepsy, pp. 78–83 (MCS Consultants, Tunbridge Wells 1976).

    Google Scholar 

  • Rowan, A.J.; Binnie, C.D.; de Beer-Pawlikowski, N.K.B.; Goedhart, D.M.; Gutter, T.; Van Der Geese, P.; Meinardi, H. and Meijer, J.W.: Sodium valproate serial monitoring of EEG and serum levels. Neurology 29: 1450–1459 (1979a).

    Article  PubMed  CAS  Google Scholar 

  • Rowan, A.J.; Binnie, C.D.; Warfield, C.A.; Meinardi, H. and Meijer, J.W.A.: The delayed effect of sodium valproate on the photoconvulsive response in man. Epilepsia 20: 61–68 (1979b).

    Article  PubMed  CAS  Google Scholar 

  • Schmidt, D.: Adverse effects of valproate. Epilepsia 25 (Suppl. 1): 44–50 (1984).

    Google Scholar 

  • Schobben, F.: Valproic acid: Pharmacokinetic aspects. British Journal of Clinical Practice Suppl. 27: 48–53 (1983).

    Google Scholar 

  • Schobben, F. and Van Der Kleijn, E.: Determination of sodium di-N-propylacetate in plasma by gas-liquid chromatography. Pharmaceutisch Weekblad 109: 30–33 (1974).

    CAS  Google Scholar 

  • Schobben, F.; Van der Kleijn, E. and Gabreels, F.J.M.: Pharmacokinetics of di-N-propylacetate in epileptic patients. European Journal of Clinical Pharmacology 8: 97–105 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Simon, D. and Penry, J.K.: Sodium di-N-propylacetate (DPA) in the treatment of epilepsy. Epilepsia 16: 549–573 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Turnbull, D.M.; Rawlins, M.D.; Weightman, D. and Chadwick, D.W.: A comparison of phenytoin and valproate in previously untreated adult epileptic patients. Journal of Neurology, Neurosurgery and Psychiatry 45: 55–59 (1982).

    Article  CAS  Google Scholar 

  • Turnbull, D.M.; Rawlins, M.D.; Weightman, D. and Chadwick, D.W.: Plasma concentrations of sodium valproate: Their clinical value. Annals of Neurology 14: 38–42 (1983).

    Article  PubMed  CAS  Google Scholar 

  • Turnbull, D.M.; Rawlins, M.D.; Weightman, D. and Chadwick, D.W.: ’Therapeutic’ serum concentrations of phenytoin: The influence of seizure type. Journal of Neurology, Neurosurgery and Psychiatry 47: 231–234 (1984).

    Article  CAS  Google Scholar 

  • Vajda, F.; Morris, P.; Drummer, O. and Bladin, P.: Studies on sodium valproate — a new anticonvulsant; in Legg (Ed.) Clinical and Pharmacological Aspects of Sodium Valproate in the Treatment of Epilepsy, pp. 91–100 (MCS Consultants, Tunbridge Wells 1976).

    Google Scholar 

  • Volans, G.N.; Berr, D.J. and Wiseman, H.M.: Overdose with sodium valproate. British Journal of Clinical Practice Suppl. 27: 54–58 (1983).

    Google Scholar 

  • Wulff, K.; Flachs, H.; Wurtz-Jorgensen, A. and Gram, L.: Clinical pharmacological aspects of valproate sodium. Epilepsia 18: 149–157 (1977).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mersey Regional Department of Medica and Surgical Neurology, Walton Hospital, Rice Lane, Liverpool, L9 1AE, England

    D. W. Chadwick (Consultant Neurologist)

Authors
  1. D. W. Chadwick
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chadwick, D.W. Concentration-Effect Relationships of Valproic Acid. Clin Pharmacokinet 10, 155–163 (1985). https://doi.org/10.2165/00003088-198510020-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-198510020-00003

Keywords

Search

Navigation